Pharma Manufacturing Market Value to Reach $863.6 Billion by 2030

News
Article

The report also references a CAGR of 7.8% through that year.

According to Vantage Market Research, the global pharmaceutical manufacturing market is estimated to be valued at $863.6 billion by 2030 and is expected to exhibit a compound annual growth (CAGR) of 7.8% between 2023 and 2030. This market grew to $510.5 billion in 2022. The research report attributes the growth to various factors, including the increase in demand for pharma products, advancements in technology, and a rise in cases of chronic disorders.

Pharma manufacturing involves numerous processes, including research & development, formulation, quality control testing, packaging, and distribution. It requires specialized facilities that comply with stringent regulations & standards to ensure product safety and efficacy. Quality control and regulatory compliance levels are crucial to ensure safe and effective drug production.

Image Credit: Vantage Market Research

Image Credit: Vantage Market Research

Notable highlights of the report include:

  • By drug development type, the outsource segment contributed over 54.3% of the total revenue share 2022.
  • By molecule type, the conventional drugs (small molecules) segment is expected to witness maximum market growth over the projected period.
  • North America led the market in 2022, contributing 42.3% of total revenue.
  • The Asia Pacific region is anticipated to witness a significant market growth in the forecast period.

Another focus point is generics, where are cost-effective alternatives to their branded counterparts. Vantage Market Research alluded to the strong demand worldwide, including in India, where generic drugs are accounting for 70-80% of the nation’s retail market.

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.